Paramount Bed Holdings (7817.T) Holds ¥3,515 as Healthcare Sector Steadies

Paramount Bed Holdings Co., Ltd. (7817.T) closed flat at ¥3,515 on the JPX today, reflecting steady demand in Japan’s medical supplies sector. The Tokyo-based manufacturer of hospital and nursing care beds maintains a market cap of ¥197.1 billion with solid operational metrics. 7817.T stock trades above its 50-day average of ¥1,126,605,950 and 200-day average of ¥281,653,632. Meyka AI rates the company with a B+ grade, signaling a buy recommendation for investors seeking exposure to healthcare infrastructure.

7817.T Stock Performance and Valuation Metrics

Paramount Bed Holdings maintains a stable price point with trading volume reaching 370,600 shares, above its average of 179,021. The stock’s year-to-date performance shows modest gains of 0.29% over three months, while the six-month return stands at 30.6%. The company’s price-to-earnings ratio of 21.46 reflects fair valuation relative to sector peers, while the price-to-book ratio of 1.44 suggests reasonable asset pricing. Revenue per share totals ¥1,908, with net income per share at ¥163.76, demonstrating consistent profitability in the medical equipment space.

Financial Strength and Dividend Appeal

The company boasts a current ratio of 3.85, indicating strong liquidity to meet short-term obligations. Paramount Bed’s debt-to-equity ratio of 0.055 ranks among the lowest in healthcare, reflecting conservative capital management. The dividend yield stands at 3.16%, with annual dividends of ¥111 per share, attracting income-focused investors. Return on equity of 6.74% and return on assets of 5.08% show steady capital efficiency. These metrics underscore why track 7817.T on Meyka for real-time updates on this financially stable operator.

Healthcare Sector Dynamics and Growth Outlook

Japan’s healthcare sector trades at an average PE of 22.92, placing 7817.T slightly below peer valuations. The industry benefits from aging demographics and rising demand for medical equipment across hospitals and nursing facilities. Paramount Bed’s three-year revenue growth of 22.5% outpaces sector averages, while gross margins of 48.9% demonstrate pricing power. Operating margins of 10.8% reflect operational efficiency in manufacturing and distribution. The company’s focus on home care products and equipment maintenance services positions it well for sustained demand growth.

Meyka AI Grade and Investment Outlook

Meyka AI rates 7817.T with a grade of B+, reflecting strong fundamentals across multiple dimensions. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The DCF score of 4 and ROA score of 4 both recommend buy, while the PE score of 2 suggests caution on valuation. These grades are not guaranteed and we are not financial advisors. The company’s stable cash position of ¥770 per share and interest coverage ratio of 192 provide substantial downside protection for shareholders.

Final Thoughts

Paramount Bed Holdings (7817.T) presents a balanced opportunity for investors seeking exposure to Japan’s medical supplies sector. The stock’s flat performance today masks underlying strength: a B+ Meyka AI grade, robust balance sheet, and attractive 3.16% dividend yield. With revenue growth of 22.5% over three years and conservative debt levels, the company demonstrates resilience in healthcare infrastructure. The current valuation at 21.46 PE remains reasonable for a stable operator with consistent profitability. Investors should monitor upcoming earnings announcements scheduled for February 2026 to assess momentum in hospital bed demand and home care expansion.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.